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Egg allergy affects about 2.6% of preschool children 
by 3 years of age, and influenza immunisation using 
egg based vaccines has been classified as a “relative 
 contra indication” (prescribe with extra caution) in this 
patient group.1 Until now the numbers of children with 
egg allergy requiring immunisation has been low, but this 
may change with the potential for a mass immunisation 
campaign. This article reviews the literature on the safety 
of flu vaccines and provides guidelines for the admin-
istration of these vaccines to children with egg allergy. 
Although egg-free flu vaccines are expected to be avail-
able for this season, the provision of sufficient amounts of 
this vaccine cannot be guaranteed at the time of writing, 
and a pragmatic strategy for the safe immunisation of 
children with egg allergy is required.
Sources and selection criteria
We identified articles using PubMed and the search 
terms “influenza” and “egg allergy”. We identified fur-
ther references within relevant papers. We found two 
randomised clinical trials, but most evidence comes 
from small case series.
what vaccines are available?
This season two varieties of flu vaccine will be available: 
a pandemic A/H1N1 strain and the normal trivalent 
seasonal flu vaccine that will contain an A/H1N1 virus 
but will not protect against the pandemic strain. There 
is an egg-free flu vaccine for seasonal immunisation, 
and it is anticipated that there will be one available for 
the pandemic strain (table 1). These egg-free vaccines 
are produced using new viral culture techniques in a 
mammalian cell line.2 3 Inactivated, split flu virus, split 
virion, subunit, or surface antigen flu vaccines are grown 
in hens’ eggs and contain residual allergenic egg white 
proteins. Some but not all of last season’s flu vaccines 
(2008) reported maximum egg protein content above 
the proposed safety cut-off of 1.2 μg/ml, with levels up 
to 2 μg/ml. Virosomal vaccines are highly purified, and 
although still grown in egg cultures, often have much less 
residual egg protein.4
what is the evidence for the current contraindications?
According to the Department of Health guidance on 
immunisation in the Green Book and manufacturer’s 
product characteristics, flu immunisation is contraindi-
cated by a confirmed anaphylaxis to a previous dose of 
the vaccine, to any component of the vaccine, or to egg 
products.5 Despite the use of anaphylaxis as a severity 
cut-off, flu vaccines have been used cautiously in indi-
viduals with egg allergy. We will look at the evidence for 
each of these contraindications in turn.
Anaphylaxis as an adverse event after immunisation 
is a rare event at about one in a million doses.6 7 There 
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SummaRy pointS
Egg-free, mammalian culture based flu vaccines should be 
given preferentially to individuals allergic to egg 
If an egg-free vaccine is not available, only vaccines with a 
stated maximum egg content <1.2 μg/ml (0.6 μg per dose) 
should be used in individuals allergic to egg
If egg based vaccine is administered to individuals with 
egg allergy, this should be done in a centre experienced in 
the management of anaphylaxis
A single dose protocol is recommended for those with less 
severe egg allergy
A two dose, split protocol can be used in those with 
anaphylaxis to egg or those with moderate or uncontrolled 
asthma
table 1 | Brands of influenza vaccine available in the UK for the 
autumn 2009 immunisation campaign*
Influenza 
vaccine type
Pandemic 
A/H1N1
Seasonal 
2009
Vaccine choice for 
individuals with egg allergy
Cell culture Celvapan 
(Baxter)
Optaflu 
(Novartis)
First
Virosome None 
available
Viroflu (Sanofi 
Pasteur MSD)
Second
Standard†‡ Pandemrix 
(GSK)
All other 
brands†
Third‡
*These brands will change between seasons, as will the egg content of 
standard vaccines.
†Standard vaccine types containing hens’ egg protein are described as 
inactivated, split flu virus, split virion, subunit, or surface antigen.
‡Brands that contain hens’ egg protein and are used in individuals with 
egg allergy should have a stated ovalbumin content preferably <1.2 μg/ml 
or 0.6 μg/dose to be in keeping with safety data (see text).
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is a paucity of published data on the risk of allergic reac-
tion to flu vaccine.8 A large population based study in 
the United States in 1976 found 11 episodes of non-fatal 
anaphylaxis in 48 million doses.9 None of the patients 
with an anaphylaxis to the flu vaccine reported a history 
of egg allergy.
Excipients in the vaccine can act as allergens in sen-
sitised individuals, as seen with gelatin in the measles, 
mumps, and rubella vaccine (MMR vaccine) during the 
1990s.10 Common residues of production found in flu 
vaccines include the stabiliser polysorbate 80 and anti-
biotics such as gentamicin, neomycin, kanamycin, and 
polymyxin B. There are no reports of anaphylaxis to flu 
vaccine caused by sensitivity to these agents.
All reported cases of anaphylaxis after flu immunisa-
tion in individuals with egg allergy occurred over 20 
years ago. At least one case of fatal anaphylaxis after 
influenza vaccine occurred in a child with egg allergy 
during the 1970s.11 In 1946 Ratner and Untracht 
described two cases of adult anaphylaxis related to flu 
vaccine and egg intolerance from their literature review; 
they also documented two children who had immediate 
allergic reactions to full strength intradermal testing with 
flu vaccine.12 The egg content of the vaccines causing 
these reactions was likely to have been much higher than 
those available today. The ovalbumin content of flu vac-
cines has been shown to change by manufacturer and by 
year.13 14 More recently, manufacturers have published 
the maximum egg content of their vaccines in their “sum-
mary of product characteristics,” which helps to make an 
assessment of their safety in egg allergy.
Can influenza vaccine be given safely in egg allergy?
Several reports have been published of the safe immu-
nisation of individuals allergic to egg with flu vaccines 
containing egg (table 2). Initial case series excluded all 
who had a positive skin prick or intradermal testing 
to the flu vaccine.11 15 16 Later case series showed that 
positive skin and intradermal tests to the vaccine did 
not predict reactivity, and that individuals with an ana-
phylaxis to egg have been immunised safely using a 
split dose protocol (six dose or two dose).17-19
The most convincing evidence comes from a pro-
spective multicentre controlled trial using a split dose 
protocol.19 Flu vaccine was administered in two doses 
30 minutes apart; the first dose was 1/10th (0.05 ml) 
and the second dose 9/10th (0.45 ml) of the recom-
mended dose. The content of egg protein in the vac-
cines used in this trial was known to be less than 1.2 
μg/ml (0.6 μg per 0.5 ml dose). Eighty three indi-
viduals with confirmed egg allergy were recruited, of 
whom 27 had a convincing history of anaphylaxis to 
egg. The 124 control participants without egg allergy 
received a standard single dose of the vaccine. All 
patients with egg allergy tolerated the split dose vac-
cination protocol without any significant allergic reac-
tion. A controlled study also showed that a virosomal 
vaccine with a single dose protocol was safe in those 
with egg allergy.20
Although these studies have cautiously established 
the safety of flu vaccines in a small sample of indi-
viduals with egg allergy, the studies are too small to 
establish the risk of anaphylaxis; however, all subjects 
tolerated a cumulative full dose of vaccine.
what do current guidelines say?
The current guidance has interpreted these data in 
different ways.14 21 22 The American Academy of Paedi-
atrics’ Red Book has recommended a graded, five injec-
tion protocol after an initial 0.05 ml of 1:10 vaccine 
dilution, in a setting with full resuscitation facilities.22 
Two variations of a two dose, split protocol have also 
been recommended: one using a 1:100 intradermal 
test before dosing, whereas the other forgoes diag-
nostics but excludes those with anaphylaxis to egg.14 21 
Neither of these guidelines incorporates the evidence 
for the safe administration of vaccine either to those 
with anaphylaxis to egg or to those apparently sensi-
tised to the vaccine (with a positive intradermal test) 
using a two dose split protocol.19 The British Society of 
Allergy and Clinical Immunology has recently ratified 
gu idelines based on our advice to members of the Pae-
diatric Allergy Group for the 2008 flu season, which 
form the basis of our recommendations.23
Common false 
contraindications to 
influenza immunisation
The following are not 
contraindications to 
immunisation with flu 
vaccine:
A history of egg allergy •	
but now able to eat eggs 
without reaction
A family history of egg •	
allergy—in a sibling or 
other family member
A family history of •	
reaction to flu or any 
other vaccine
table 2 | Immunisation of individuals allergic to egg with influenza vaccine
Influenza vaccine 
diagnostics
Positive vaccine  
diagnostics
Previous anaphylaxis  
to egg
Vaccine administration  
schedule
Immediate adverse  
events
Davies and Pepys15 SPT neat 7/22 Not stated Not given Nil*
Bierman et al11 SPT neat 0/142† 1/142 2 single doses, 4 weeks apart Nil
IDT 1:100 12/142 12/142 “severe” Not given if IDT positive Nil
Miller et al16 IDT 1:100 5/42 3/42 “severe” Not given Nil
Murphy and Strunk17 SPT 1:10,  
IDT 1:100
0/6 (SPT) 6/6 (IDT) Not stated Six doses, graded‡ All had asthma, 1 wheezed 20 
min after second dose
Anolik et al18 IDT 1:100 8/8 (egg allergy group),  
5/8 (controls)
Not stated Six doses, graded‡ Nil
James et al19 SPT neat 4/83 (egg allergy group), 
1/124 (controls)
27/83 Split dose§ Nil
Esposito et al20 SPT neat 0/44 (egg allergy group), 
0/44 (controls)
11/44 Single dose of virosmal vaccine Nil
ITD= intradermal dilutional testing.
SPT=skin prick testing.
*Two (of seven) reported adverse reactions to a previous dose of influenza vaccine.
†Two children allergic to eggs developed a positive IDT result before the second dose of vaccine, which was then withheld.
‡Six dose protocol of 0.05 ml (1:100 dilution); 0.05 ml (1:10); 0.05 ml neat vaccine; then 0.1 ml, 0.15 ml, and 0.2 ml (neat) at intervals of 15 minutes, with a further split dose four weeks later. 
§Two dose, split protocol of 1/10th, followed by 9/10th 30 minutes later using a vaccine with <1.2 μg/ml ovalbumin content.
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what should we do?
Given the likelihood of mass immunisation to flu, 
including preschool children, a pragmatic approach is 
essential to ensure that individuals with egg allergy are 
protected, both from the disease and from the risks of 
 immunisation.
is the child allergic to egg?
Egg allergy is easily diagnosed from a clear history of 
immediate allergic reaction to egg or to a food con-
taining egg. All children with immediate reactions to 
egg, including those with localised rashes on exposure, 
should have skin prick testing or estimation of specific 
IgE to confirm the diagnosis. Specialist advice may be 
needed if the diagnosis remains uncertain. We have out-
lined clinical decision steps in the algorithm (figure).
Anaphylaxis to chicken meat, feathers, and dander 
has been reported as a contraindication to flu vaccine 
by some manufacturers. Although such allergies are rare, 
no cases of anaphylaxis to flu immunisation in such indi-
viduals have been reported. These rare allergies remain a 
theoretical risk and in the absence of any firm clinical data 
should be treated in the same way as egg allergy.
Many children outgrow their egg allergy in the first 
few years of life. If a child can eat lightly cooked egg 
(such as a spoonful of scrambled egg) without reaction 
then they are no longer allergic. We do not recommend 
testing children allergic to egg by a trial at home of food 
containing egg because of the risk of an unsupervised 
allergic reaction. A specialist should assess a child’s cur-
rent sensitivity. Children tolerating egg in baked products 
(such as cake) but not boiled or scrambled egg are still 
potentially at risk of severe reaction.
which vaccine should be used?
We recommend that all individuals with egg allergy 
should be immunised with a mammalian culture based 
flu vaccine (table 1). If a mammalian cell culture v accine 
is not available then we recommend using a virosomal 
vaccine for seasonal flu as this has the lowest egg content 
of any vaccine based on hens’ egg and has clinical data 
to support its use.20
Flu vaccines that contain egg should be used with 
caution and only if other vaccines are not available. A 
careful assessment should weigh the risks of immuni-
sation against risk of infection with the flu virus. The 
risk-benefit for each individual will depend on host fac-
tors such as underlying chronic illness and current or 
planned immunosuppression and on viral factors such 
as the local prevalence and virulence of the seasonal or 
pandemic virus. In keeping with available safety data, the 
vaccine should have a stated maximum egg content of 
<1.2 μg/ml (0.6 μg per dose).19 The ovalbumin content 
of the pandemic vaccine Pandemrix (GSK) is not known. 
We recommend that the maximum egg concentration is 
added to the “summary of product characteristics” before 
its licensure.
Adverse events to any flu vaccine should be reported 
to the Medicines Healthcare Regulatory Agency’s Y ellow 
Card scheme (http://yellowcard.mhra.gov.uk). 
is all egg allergy the same?
Children with positive allergy diagnostics to egg by skin 
prick testing or specific IgE estimation have the potential 
for a generalised reaction when presented with allergen 
via the parenteral route of intramuscular immunisation, 
even if reactions on oral exposure have been mild. Until 
better safety data are available we recommend that these 
individuals are immunised in a facility with staff experi-
enced in treating children with anaphylaxis, most likely 
secondary care.
We have divided individuals with egg allergy into 
two risk groups based on our opinion of their po tential 
for anaphylaxis to the vaccine (table 3).24 Most  children 
with egg allergy have reactions involving the skin. For 
the easy application of our recommendations we have 
simplified the diagnosis of anaphylaxis.25 26  If any 
uncertainty remains about the nature of the  allergic 
Algorithm for the immunisation of individuals allergic to egg with influenza vaccine 
Is influenza immunisation indicated in an egg allergic individual?
Adverse reaction to previous dose of influenza vaccine? 
Immunise with mammalian cell based vaccine
Influenza immunisation contraindicated
Ever eaten egg?
Past adverse reaction to egg?
Previous anaphylaxis to egg?‡
Immunise with single dose schedule in primary care
Immunise with single
dose schedule in hospital
Egg allergy diagnostics?†
Moderate or uncontrolled asthma?§
No
No
No
No
Yes
Not available?
Negative
Positive
Yes
Yes
Previous adverse reaction to a shared
component of the influenza vaccine?
Currently eats eggs without reaction?*
YesNo
Yes
No
Yes
Yes
Immunise with split dose schedule in hospital
*Able to eat a portion of eggs (not just egg when baked in foods such as in cakes and biscuits) without immediate
  allergic reaction 
†A positive skin prick test, specific IgE estimation, or food challenge 
‡A history of a severe allergic reaction affecting at least one of the following areas:  airway (throat tightness, sensation
  of closure, stridor, hoarseness); breathing (tachypnoea, respiratory distress, dyspnoea, wheeze, hypoxia); circulation
  (collapse, hypotension, shock with or without loss of consciousness, severe abdominal pain) 
§Uncontrolled asthma or using preventer drugs at BTS/SIGN step 3 or higher 
table 3 | Immunisation with an egg containing vaccine
Worst previous reaction to egg Vaccine protocol
Lower risk Previous mild gastrointestinal or 
dermatological reaction to egg and positive 
diagnostics; orpositive diagnostics but never 
knowingly exposed to egg
Single dose schedule 0.5 ml intramuscular dose 
of a virosomal vaccine or a vaccine with low egg 
content (<1.2 μg/ml) if virosomal not available
Higher risk Previous respiratory or cardiovascular 
reaction to egg, and positive diagnostics; 
or“lower risk” individual with uncontrolled 
asthma treated at BTS/SIGN step 3 or higher
Two dose, split protocol of 0.05 ml 
intramuscularly, followed 30 minutes later by 0.45 
ml of a virosomal vaccine or a vaccine with low egg 
content (<1.2 μg/ml) if virosomal not available
This table considers the approach if an egg-free vaccine is not available. Mild gastrointestinal and dermatological 
reactions include urticaria, angio-oedema, and vomiting. Anaphylaxis is characterised by symptoms involving the 
airway and respiratory tract, such as pharyngeal oedema, stridor, respiratory distress, and wheeze. Cardiovascular 
complications include circulatory shock, hypotension, severe abdominal pain, or collapse. Positive diagnostics 
are skin prick and specific IgE tests to egg protein.
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reaction they should be considered to be in the 
higher risk group.
Asthma is a known risk factor for life threatening 
anaphylaxis, and so we have dealt with children with 
moderate to severe asthma differently, by including 
them in the higher risk group irrespective of the 
severity of their previous reactions to egg.27
As an arbitrary cut-off we have used step 3 of the 
British Thoracic Society/SIGN guidelines, where a 
long acting β2 agonist is added to inhaled corticos-
teroid therapy.28 Children who have uncontrolled 
asthma should also be included in the higher risk 
group. We do not recommend that children with 
acute asthma are immunised; it should be deferred 
until they have recovered.
We recommend that high risk children should 
always be immunised in secondary care owing to 
the availability of advanced paediatric resuscita-
tion facilities. Unlike normal immunisation advice 
to wait for 20 minutes after the procedure, we 
advise that higher risk patients should remain on 
the premises for 60 minutes after immunisation, 
in keeping with standard allergen immunotherapy 
practice (where allergic reaction is more commonly 
encountered) and to refrain from strenuous exercise 
for 24 hours.
the a/H1n1 vaccine
The A/H1N1 vaccine is expected to consist of 
two doses three weeks apart. Both doses should be 
pr ovided in a centre experienced in the manage-
ment of anaphylaxis. The second dose of the same 
vaccine can be given in a single 0.5 ml intramuscu-
lar injection provided that the first dose has been 
tolerated.
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AdditionAl eduCAtionAl resourCes 
For patients
NHS Immunisation Information (www.immunisation.nhs.•	
uk)—NHS website giving advice on vaccines, disease, 
and immunisation in the UK
For healthcare professionals
•	Immunisation against infectious disease—“the 
green book.” (www.dh.gov.uk/en/Publichealth/
Healthprotection/Immunisation/Greenbook/
DH_4097254)—Department of Health publication 
providing advice on immunisation
BSACI (www.bsaci.org/index.php?option=com_•	
clinics&Itemid=26)—This website of the British Society 
for Allergy and Clinical Immunology provides information 
about where the UK NHS and Irish allergy clinics are 
located, and what services they operate
tips For non-speCiAlists
Celvapan (Baxter), a pandemic A/H1N1 vaccine, and •	
Optiflu (Novartis), a seasonal influenza vaccine are grown 
in a mammalian cell culture system and are egg-free
Other flu vaccines are prepared in hens’ eggs and may •	
contain small amounts of egg protein
Individuals with severe egg allergy face a risk of •	
anaphylaxis with flu vaccines that contain egg
